+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2024-2030- Product Image
Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2024-2030- Product Image
Sale

Global Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829949
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radiopharmaceuticals Market size was estimated at USD 5.15 billion in 2023, USD 5.48 billion in 2024, and is expected to grow at a CAGR of 6.47% to reach USD 8.00 billion by 2030.

Radiopharmaceuticals are a unique category of medicinal formulations containing radioisotopes that are used in the field of nuclear medicine. These compounds, which are characterized by their ability to emit radiation, serve multiple purposes, including diagnosis, therapy, and research. Radiopharmaceuticals offer significant value in both the detection and treatment of disease, enhancing the capability for early diagnosis, monitoring of disease progression, and effectiveness of therapeutic interventions. Radiopharmaceutical compounds are experiencing significant adoption, driven by the rising prevalence of chronic diseases such as cancer and cardiovascular disorders that require advanced diagnostic techniques.

Technological advancements in imaging technologies, such as PET and SPECT, are also catalyzing the radiopharmaceuticals market growth. Additionally, the increasing adoption of personalized medicine and targeted therapy approaches boosts the demand for radioisotopes in therapeutic applications. Despite considerable growth prospects, the radiopharmaceuticals market faces challenges, including stringent regulatory requirements that result in longer approval times for new radiopharmaceuticals. High costs for radiopharmaceutical development and production, as well as the requirement for specialized facilities and trained personnel, add to the list of challenges facing the industry. However, the increasing investment in research and development provides ample opportunities for innovation and expansion in the radiopharmaceutical market. Furthermore, ongoing advancements in theranostics, which combine diagnostic and therapeutic capabilities in a single agent, present new avenues for integrative healthcare solutions and personalized treatment, positioning the radiopharmaceuticals market for sustained growth.

Regional Insights

The radiopharmaceutical market in the Americas has shown robust growth, driven by advancements in nuclear medicine and the advanced healthcare infrastructure. The United States contributes majorly to the market with its substantial investments in R&D and favorable reimbursement policies. Canada and Latin America are also experiencing growth, albeit at a slower pace, owing to increasing awareness and improving healthcare facilities. Europe is a significant contributor to the radiopharmaceutical market within the EMEA region, with adoption fuelled by the rising incidence of chronic illnesses, the aging population, and increased healthcare expenditure.

Germany, France, and the UK have strong market positions due to their advanced healthcare systems and supportive government initiatives. The Middle East and Africa are emerging markets with untapped potential, characterized by increasing investment in healthcare infrastructure and a growing demand for diagnostic services. However, the scarcity of skilled professionals and economic variability across countries may challenge market expansion in this region. The Asia-Pacific radiopharmaceutical market is experiencing rapid growth, offering substantial opportunities due to its strong research base in evolving healthcare sectors. Countries such as China, Japan, Australia, and South Korea are at the forefront of this growth. The increasing government initiatives to modernize healthcare are propelling market development.

Market Trends by Segment

  • Procedural Volume: Ongoing advancements in brachytherapy isotopes procedure
  • Application: Increasing utilization of radiopharmaceuticals in therapeutic procedures

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

Bristol-Myers Squibb (BMS) has strategically acquired RayzeBio, a leader in the field of targeted radiopharmaceuticals to unite BMS's expansive resources with RayzeBio's innovative platform designed to develop and optimize precision radioligands aimed at treating cancer more effectively. This move underlines the growing potential and interest in radiopharmaceuticals as a key area within precision oncology therapeutics. RayzeBio's focused expertise in the development of targeted radiotherapies complements BMS's commitment to advancing cancer treatment and diversifying therapeutic options for patients.

New CRP to Develop new Technetium-99m Radiopharmaceuticals for Disease Diagnosis

The International Atomic Energy Agency (IAEA) launched a coordinated research project (CRP) aimed at developing innovative technetium-99m (Tc-99m) radiopharmaceuticals. Tc-99m, widely valued for its diagnostic capabilities, plays a vital role in over 30 million medical imaging procedures globally each year. This new CRP seeks to expand the clinical applications of Tc-99m, offering potentially improved detection and management of a variety of diseases. By fostering collaboration between researchers, nuclear medicine practitioners, and experts, the project is expected to yield a portfolio of cutting-edge Tc-99m radiopharmaceuticals, tailored to meet diverse patient needs and push the envelope of nuclear medicine.

With USD 56 Million, a Mayo Clinic-backed Startup takes aim at Radiopharmaceutical Roadblocks

Nucleus RadioPharma has secured a substantial USD 56 million in Series A funding. The investment pool includes prominent backers such as Eclipse Ventures, GE HealthCare, and esteemed academic institutions such as the Mayo Clinic and the University of Missouri. The infusion of new capital is earmarked for establishing a supply chain facility in the vicinity of Rochester, Minnesota, to bolster production capabilities. The recent partnership with NorthStar Medical Radioisotopes to secure a supply of actinium-225 underscores Nucleus's commitment to overcoming the production hurdles that have traditionally impeded the sector's growth, signaling a transformative leap forward in the treatment of cancer.

Key Company Profiles

The report delves into recent significant developments in the Radiopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alliance Holdings Medical Limited, Bayer AG, Bracco Group, BWX Technologies. Inc., BWXT Medical Ltd., Cardinal Health, Inc., Clarity Pharmaceuticals, Curium Pharma, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products Co., Fusion Pharmaceuticals Inc., GE HealthCare Technologies, Inc., Global Medical Solutions, Institute of Isotopes Co. Ltd., International Isotopes, Inc., IsoTherapeutics Group, LLC, Isotopia Molecular Imaging Ltd., Jubilant Pharma Holdings Inc., Lantheus Medical Imaging, Inc., Mallinckrodt PLC, Medi-Radiopharma, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., SHINE Medical Technologies, Siemens Healthineers AG, Sinotau Pharmaceutical Group, and State Atomic Energy Corporation Rosatom.

This research report offers invaluable insights into various crucial aspects of the Radiopharmaceuticals Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence and Prevalence of Target Conditions
5.1.1.2. Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.1.1.3. Initiatives To Reduce The Demand-Supply Gap of mo-99
5.1.2. Restraints
5.1.2.1. Shorter Life of Radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Adoption of Radiopharmaceuticals in Neurological Applications
5.1.3.2. Rising Number of Diagnostic Centers Especially in Developing Countries
5.1.4. Challenges
5.1.4.1. High Equipment Prices and Limited Hospital Budget
5.2. Market Segmentation Analysis
5.2.1. Procedural Volume: Ongoing advancements in brachytherapy isotopes procedure
5.2.2. Application: Increasing utilization of radiopharmaceuticals in therapeutic procedures
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Radiopharmaceuticals Market, by Type
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.3. Therapeutic Nuclear Medicine
7. Radiopharmaceuticals Market, by Procedural Volume
7.1. Introduction
7.2. Diagnostic Procedures
7.3. Therapeutic Procedures
8. Radiopharmaceuticals Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.3. Therapeutic Applications
9. Americas Radiopharmaceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Radiopharmaceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Radiopharmaceuticals Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
12.3.2. New CRP to Develop new Technetium-99m Radiopharmaceuticals for Disease Diagnosis
12.3.3. With USD 56 Million, a Mayo Clinic-backed Startup takes aim at Radiopharmaceutical Roadblocks
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. RADIOPHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RADIOPHARMACEUTICALS MARKET DYNAMICS
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 101. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 102. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 103. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 104. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 105. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 106. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 107. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 108. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 109. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 110. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 111. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2023 (USD MILLION)
TABLE 112. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2024-2030 (USD MILLION)
TABLE 113. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 114. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 115. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 116. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 117. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 118. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 119. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 120. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 121. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 122. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 123. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 124. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 125. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 128. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 129. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 130. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 131. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 132. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 133. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 134. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 135. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 136. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 137. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 138. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 139. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 140. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 141. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 142. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 143. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 144. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 145. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 148. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 149. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 150. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 151. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 152. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 153. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 154. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 155. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 160. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 161. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 162. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 163. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 164. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 165. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 166. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 167. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 168. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 169. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 170. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 171. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 172. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 173. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 174. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 175. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 176. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 177. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 180. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 181. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 182. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 183. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 184. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 185. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 186. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 187. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 190. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 191. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 192. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 193. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 194. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 195. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 196. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 197. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 198. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 199. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 200. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 201. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 202. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 203. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 204. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 205. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 206. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 207. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 210. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 211. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 212. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 213. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 214. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 215. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 216. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 217. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 220. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 221. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 222. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 223. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 224. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 225. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 226. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 227. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 228. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 229. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 230. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 231. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 232. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 233. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 234. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 235. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 236. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 237. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 240. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 241. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 242. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 243. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 244. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 245. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 246. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 247. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 250. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 251. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 252. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 253. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 254. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 255. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 256. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 257. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 258. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 259. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 260. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 261. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 262. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 263. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 264. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 265. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 266. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 267. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 270. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 271. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 272. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 273. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 274. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 275. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 276. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 277. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 280. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 281. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 282. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 283. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 284. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 285. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 286. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 287. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
TABLE 288. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
TABLE 289. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2023 (USD MILLION)
TABLE 290. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2024-2030 (USD MILLION)
TABLE 291. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2023 (USD MILLION)
TABLE 292. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2024-2030 (USD MILLION)
TABLE 293. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 294. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 295. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2023 (USD MILLION)
TABLE 296. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2024-2030 (USD MILLION)
TABLE 297. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 300. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 301. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 302. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 303. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 304. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 305. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2023 (USD MILLION)
TABLE 306. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2024-2030 (USD MILLION)
TABLE 307. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 308. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 310. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 312. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 314. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 315. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
TABLE 316. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
TABLE 317. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2023 (USD MILLION)
TABLE 318. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2024-2030 (USD MILLION)
TABLE 319. ASIA-PACIFIC

Companies Mentioned

  • Alliance Holdings Medical Limited
  • Bayer AG
  • Bracco Group
  • BWX Technologies. Inc.
  • BWXT Medical Ltd.
  • Cardinal Health, Inc.
  • Clarity Pharmaceuticals
  • Curium Pharma
  • Eckert & Ziegler Group
  • Eczacibasi-Monrol Nuclear Products Co.
  • Fusion Pharmaceuticals Inc.
  • GE HealthCare Technologies, Inc.
  • Global Medical Solutions
  • Institute of Isotopes Co. Ltd.
  • International Isotopes, Inc.
  • IsoTherapeutics Group, LLC
  • Isotopia Molecular Imaging Ltd.
  • Jubilant Pharma Holdings Inc.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt PLC
  • Medi-Radiopharma
  • Northstar Medical Technologies LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • SHINE Medical Technologies
  • Siemens Healthineers AG
  • Sinotau Pharmaceutical Group
  • State Atomic Energy Corporation Rosatom

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 8 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Global Radiopharmaceuticals Market Report and Forecast 2023-2031 - Product Image

Global Radiopharmaceuticals Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Nuclear Medicine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Nuclear Medicine Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From
Radiopharmaceuticals - Global Strategic Business Report - Product Image

Radiopharmaceuticals - Global Strategic Business Report

  • Report
  • 739 Pages
  • Global
From
Global Diagnostic Radiopharmaceuticals and Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Diagnostic Radiopharmaceuticals and Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 118 Pages
  • Global
From
Global Nuclear Medicine Market Report and Forecast 2023-2031 - Product Image

Global Nuclear Medicine Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From

About the Radiopharmaceutical Market

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect. The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals. Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.